Specifically, we have identified FAP+ CAFs as a conserved cancer-associated fibroblast subtype that is significantly associated with patient survival, albeit with functional and spatial distribution heterogeneity within different forms of liver cancer. The gene discussed is FAP; the disease is liver cancer.